{"BackgroundSteroidal": [0], "mineralocorticoid": [1, 45], "receptor": [2, 46], "antagonists": [3], "reduce": [4], "morbidity": [5], "and": [6, 13, 25, 40, 54, 74, 140, 151, 175, 214, 240, 260, 270, 293], "mortality": [7], "among": [8], "patients": [9, 50, 70, 170, 184, 232, 266], "with": [10, 22, 51, 71, 254, 267], "heart": [11, 23, 52, 72, 120, 138, 205, 268, 290], "failure": [12, 24, 53, 73, 121, 206, 269, 291], "reduced": [14, 27, 56, 262, 272], "ejection": [15, 30, 59, 78, 275], "fraction,": [16, 276], "but": [17], "their": [18], "efficacy": [19, 39], "in": [20, 49, 84, 106, 166, 171, 180, 185, 210, 216, 279], "those": [21], "mildly": [26, 55, 271], "or": [28, 57, 82, 98, 103, 130, 134, 273], "preserved": [29, 58, 274], "fraction": [31, 60, 79], "has": [32], "not": [33], "been": [34], "established.": [35], "Data": [36], "regarding": [37], "the": [38, 43, 148, 172, 186, 211, 217], "safety": [41, 152], "of": [42, 80, 95, 117, 147, 159, 168, 182, 203, 231, 258, 264, 284, 287], "nonsteroidal": [44], "antagonist": [47], "finerenone": [48, 90, 173, 212, 277], "are": [61], "needed.MethodsIn": [62], "this": [63], "international,": [64], "double-blind": [65], "trial,": [66], "we": [67], "randomly": [68], "assigned": [69], "a": [75, 85, 92, 115, 128, 156, 261, 280, 285], "left": [76], "ventricular": [77], "40%": [81], "greater,": [83], "1:1": [86], "ratio,": [87, 190, 221, 244], "to": [88, 108, 197, 226, 249], "receive": [89], "(at": [91], "maximum": [93], "dose": [94], "20": [96], "mg": [97, 100], "40": [99], "once": [101], "daily)": [102], "matching": [104], "placebo,": [105], "addition": [107], "usual": [109], "therapy.": [110], "The": [111, 145, 200, 229], "primary": [112, 149], "outcome": [113, 150], "was": [114, 208, 238, 252], "composite": [116, 286], "total": [118, 201, 288], "worsening": [119, 204, 289], "events": [122, 164, 178, 207, 292], "(with": [123], "an": [124, 255], "event": [125], "defined": [126], "as": [127], "first": [129], "recurrent": [131], "unplanned": [132], "hospitalization": [133], "urgent": [135], "visit": [136], "for": [137], "failure)": [139], "death": [141, 294], "from": [142, 235, 295], "cardiovascular": [143, 236, 296], "causes.": [144], "components": [146], "were": [153], "also": [154], "assessed.ResultsOver": [155], "median": [157], "follow-up": [158], "32": [160], "months,": [161], "1083": [162], "primary-outcome": [163, 177], "occurred": [165, 179], "624": [167], "3003": [169], "group,": [174], "1283": [176], "719": [181], "2998": [183], "placebo": [187, 218], "group": [188, 213, 219], "(rate": [189, 220], "0.84;": [191], "95%": [192, 223, 246], "confidence": [193], "interval": [194], "[CI],": [195], "0.74": [196], "0.95;": [198], "P=0.007).": [199], "number": [202], "842": [209], "1024": [215], "0.82;": [222], "CI,": [224, 247], "0.71": [225], "0.94;": [227], "P=0.006).": [228], "percentage": [230], "who": [233], "died": [234], "causes": [237, 297], "8.1%": [239], "8.7%,": [241], "respectively": [242], "(hazard": [243], "0.93;": [245], "0.78": [248], "1.11).": [250], "Finerenone": [251], "associated": [253], "increased": [256], "risk": [257, 263], "hyperkalemia": [259], "hypokalemia.ConclusionsIn": [265], "resulted": [278], "significantly": [281], "lower": [282], "rate": [283], "than": [298], "placebo.": [299], "(Funded": [300], "by": [301], "Bayer;": [302], "FINEARTS-HF": [303], "ClinicalTrials.gov": [304], "number,": [305], "NCT04435626.)": [306]}